John M Ketcham

age ~41

from Cary, NC

Get Report

Connected to:

John Ketcham Phones & Addresses

Cary, NC
4804 14Th St, Ocala, FL 34471
2060 31St St, Ocala, FL 34471
San Diego, CA
San Mateo, CA
Austin, TX
Gainesville, FL
Oviedo, FL
Rancho Cucamonga, CA
3113 Fontana Dr, Austin, TX 78704

Work

Company:

Plews Shadley Racher & Braun LLP
Address:

Specialities

Civil Litigation • Commercial Litigation • Insurance Coverage • Environmental Litigation • Appellate Practice • Environmental Law • Marijuana Law

Lawyers & Attorneys

John Ketcham - Lawyer

view source

Office:

Plews Shadley Racher & Braun LLP

Specialties:

Civil Litigation
Commercial Litigation
Insurance Coverage
Environmental Litigation
Appellate Practice
Environmental Law
Marijuana Law

ISLN:

905907732

Admitted:

1988

University:

Gordon Conwell Theological Seminary, M.Div., 1983; Indiana University, B.A., 1980

Law School:

University of Michigan, J.D., 1987

Resumes

John Ketcham

view source

Location:

United States

Medicine Doctors

John P. Ketcham

view source

Specialties:

Anesthesiology

Work:

Oregon Anesthesiology GroupOregon Anesthesiology Group PC
9205 SW Barnes Rd, Portland, OR 97225
(503)2999906 (phone), (503)2952232 (fax)

Oregon Anesthesiology Group
707 SW Washington St STE 700, Portland, OR 97205
(503)2999906 (phone), (503)2952232 (fax)

Education:

Medical School
University of Colorado School of Medicine at Denver
Graduated: 2001

Languages:

English

Description:

Dr. Ketcham graduated from the University of Colorado School of Medicine at Denver in 2001. He works in Portland, OR and 1 other location and specializes in Anesthesiology. Dr. Ketcham is affiliated with Legacy Meridian Park Hospital and Providence Saint Vincent Medical Center.

Us Patents

Imidazo[1,2-C]Pyrimidine Derivatives As Prc2 Inhibitors For Treating Cancer
view source
US Patent:

20220274990, Sep 1, 2022
Filed:

Jun 3, 2020
Appl. No.:

17/615778
Inventors:

- San Diego CA, US
John Michael KETCHAM - San Diego CA, US
Aaron Craig BURNS - San Diego CA, US
International Classification:

C07D 487/04
Abstract:

Disclosed are compounds that inhibit Polycomb Repressive Complex 2 (PRC2) activity. In particular, disclosed are compounds of Formula (I) and pharmaceutical compositions thereof, and methods of using the compounds and pharmaceutical compositions in, for example, methods of treating cancer.

Sos1 Inhibitors
view source
US Patent:

20230101312, Mar 30, 2023
Filed:

Feb 23, 2021
Appl. No.:

17/801733
Inventors:

- San Diego CA, US
John Michael Ketcham - San Diego CA, US
Christopher Ronald Smith - San Diego CA, US
John David Lawson - San Diego CA, US
Aaron Craig Burns - San Diego CA, US
Xiaolun Wang - San Diego CA, US
International Classification:

C07D 471/04
C07D 217/22
C07D 401/04
C07D 409/12
C07D 413/14
Abstract:

The present invention relates to compounds that inhibit Son of sevenless homolog 1 (SOS1) activity. In particular, the present invention relates to compounds, pharmaceutical compositions and methods of use, such as methods of treating cancer using the compounds and pharmaceutical compositions of the present invention.

Kras G12D Inhibitors
view source
US Patent:

20230077225, Mar 9, 2023
Filed:

Jul 20, 2022
Appl. No.:

17/869575
Inventors:

- San Diego CA, US
- Boulder CO, US
James Gail Christensen - San Diego CA, US
John Michael Ketcham - San Diego CA, US
John David Lawson - Carlsbad CA, US
Matthew Arnold Marx - San Diego CA, US
Christopher Ronald Smith - San Diego CA, US
Shelley Allen - Boulder, CO
James F. Blake - Longmont CO, US
Mark Joseph Chicarelli - Boulder CO, US
Joshua Ryan Dahlke - Longmont CO, US
Donghua Dai - Superior CO, US
Jay Bradford Fell - Longmont CO, US
John Peter Fischer - Longmont CO, US
Macedonio J. Mejia - Denver CO, US
Brad Newhouse - Boulder CO, US
Phong Nguyen - Boulder CO, US
Jacob Matthew O'Leary - Denver CO, US
Spencer Pajk - Boulder CO, US
Martha E. Rodriguez - Boulder CO, US
Tony P. Tang - Boulder CO, US
Guy P.A. Vigers - Boulder CO, US
Qian Zhao - Boulder CO, US
Dean Russell Kahn - Boulder CO, US
John Gaudino - Boulder CO, US
Michael Christopher Hilton - Boulder CO, US
International Classification:

C07D 519/00
Abstract:

The present invention relates to compounds that inhibit KRas G12D. In particular, the present invention relates to compounds that inhibit the activity of KRas G12D, pharmaceutical compositions comprising the compounds and methods of use therefor.

Mta-Cooperative Prmt5 Inhibitors
view source
US Patent:

20230054883, Feb 23, 2023
Filed:

Sep 12, 2022
Appl. No.:

17/942367
Inventors:

- San Diego CA, US
Christopher Ronald Smith - San Diego CA, US
Matthew Arnold Marx - San Diego CA, US
John Michael Ketcham - San Diego CA, US
Aaron Craig Burns - San Diego CA, US
John David Lawson - Carlsbad CA, US
Svitlana Kulyk - Redwood City CA, US
Jon Kuehler - San Diego CA, US
Anthony Ivetac - San Diego CA, US
International Classification:

C07D 471/04
C07D 237/32
C07D 401/10
C07D 403/10
C07D 403/12
C07D 413/10
C07D 413/14
C07D 417/10
C07D 401/14
C07D 487/04
C12N 9/10
Abstract:

The present invention relates to compounds that inhibit Protein Arginine N-Methyl Transferase 5 (PRMT5) activity. In particular, the present invention relates to compounds, pharmaceutical compositions and methods of use, such as methods of treating cancer using the compounds and pharmaceutical compositions of the present invention.

Ubiquitin-Specific-Processing Protease 7 (Usp7) Modulators And Uses Thereof
view source
US Patent:

20210317134, Oct 14, 2021
Filed:

Mar 5, 2020
Appl. No.:

16/810376
Inventors:

- South San Francisco CA, US
John Michael Ketcham - San Mateo CA, US
Maureen Kay Reilly - San Francisco CA, US
Berenger Biannic - San Mateo CA, US
Minna Hue Thanh Bui - Oakland CA, US
Dennis X. Hu - San Mateo CA, US
David Juergen Wustrow - Los Gatos CA, US
Emily Karbarz - Burlingame CA, US
Xinping Han - Daly City CA, US
Grant Shibuya - South San Francisco CA, US
Jack Maung - Daly City CA, US
Maksim Osipov - Redwood City CA, US
International Classification:

C07D 495/04
C07D 491/048
C07D 405/14
C07D 471/04
C07D 519/00
C07D 498/04
Abstract:

Disclosed herein, inter alia, compounds and methods of use thereof for the modulation of USP7 activity.

Prc2 Inhibitors
view source
US Patent:

20210101904, Apr 8, 2021
Filed:

Dec 9, 2020
Appl. No.:

17/116270
Inventors:

- San Diego CA, US
Matthew Randolph LEE - Del Mar CA, US
Thomas P. BOBINSKI - San Diego CA, US
Aaron Craig BURNS - San Diego CA, US
Nidhi ARORA - San Diego CA, US
James Gail CHRISTENSEN - San Diego CA, US
John Michael KETCHAM - San Diego CA, US
International Classification:

C07D 487/04
Abstract:

The present invention relates to compounds that inhibit Polycomb Repressive Complex 2 (PRC2) activity. In particular, the present invention relates to compounds, pharmaceutical compositions and methods of use, such as methods of treating cancer using the compounds and pharmaceutical compositions of the present invention.

Mta-Cooperative Prmt5 Inhibitors
view source
US Patent:

20210078994, Mar 18, 2021
Filed:

Sep 11, 2020
Appl. No.:

16/948312
Inventors:

- San Diego CA, US
Christopher Ronald Smith - San Diego CA, US
Matthew Arnold Marx - San Diego CA, US
John Michael Ketcham - San Diego CA, US
Aaron Craig Burns - San Diego CA, US
John David Lawson - Carlsbad CA, US
Svitlana Kulyk - Redwood City CA, US
Jon Kuehler - San Diego CA, US
Anthony Ivetac - San Diego CA, US
International Classification:

C07D 471/04
C07D 237/32
C07D 401/10
C07D 403/12
C07D 417/10
C07D 403/10
C07D 413/10
C07D 413/14
Abstract:

The present invention relates to compounds that inhibit Protein Arginine N-Methyl Transferase 5 (PRMT5) activity. In particular, the present invention relates to compounds, pharmaceutical compositions and methods of use, such as methods of treating cancer using the compounds and pharmaceutical compositions of the present invention.

Mta-Cooperative Prmt5 Inhibitors
view source
US Patent:

20210079003, Mar 18, 2021
Filed:

Sep 11, 2020
Appl. No.:

17/018738
Inventors:

- San Diego CA, US
Christopher Ronald Smith - San Diego CA, US
Matthew Arnold Marx - San Diego CA, US
John Michael Ketcham - San Diego CA, US
Aaron Craig Burns - San Diego CA, US
John David Lawson - Carlsbad CA, US
Svitlana Kulyk - Redwood City CA, US
Jon Kuehler - San Diego CA, US
Anthony Ivetac - San Diego CA, US
International Classification:

C07D 487/04
C07D 237/32
C07D 401/10
C07D 403/10
C07D 417/10
C07D 471/04
C07D 413/14
C07D 401/14
C12N 9/10
Abstract:

The present invention relates to compounds that inhibit Protein Arginine N-Methyl Transferase 5 (PRMT5) activity. In particular, the present invention relates to compounds, pharmaceutical compositions and methods of use, such as methods of treating cancer using the compounds and pharmaceutical compositions of the present invention.